000 | 01979 a2200529 4500 | ||
---|---|---|---|
005 | 20250513214210.0 | ||
264 | 0 | _c20000825 | |
008 | 200008s 0 0 eng d | ||
022 | _a0165-5728 | ||
024 | 7 |
_a10.1016/s0165-5728(00)00281-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOzenci, V | |
245 | 0 | 0 |
_aMultiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta. _h[electronic resource] |
260 |
_bJournal of neuroimmunology _cAug 2000 |
||
300 |
_a236-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 |
_aInflammation _xenzymology |
650 | 0 | 4 |
_aInterferon-beta _xpharmacology |
650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
650 | 0 | 4 |
_aInterleukins _xmetabolism |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xgenetics |
650 | 0 | 4 |
_aMatrix Metalloproteinase 7 _xgenetics |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
650 | 0 | 4 |
_aMatrix Metalloproteinases _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xgenetics |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aKouwenhoven, M | |
700 | 1 | _aTeleshova, N | |
700 | 1 | _aPashenkov, M | |
700 | 1 | _aFredrikson, S | |
700 | 1 | _aLink, H | |
773 | 0 |
_tJournal of neuroimmunology _gvol. 108 _gno. 1-2 _gp. 236-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(00)00281-2 _zAvailable from publisher's website |
999 |
_c10850654 _d10850654 |